학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 73,062건 | 목록
1~20
Academic Journal
Cytotechnology: Incorporating Methods in Cell ScienceInternational Journal of Cell Culture and Biotechnology. 78(1)
Report
A Randomized Phase 2 Clinical Trial to Evaluate the Activity of ATRA in Combination With Anastrozole in Pre-operative Phase of Operable HR-positive/HER2-negative Early Breast Cancer (ATRA )
Academic Journal
Ortiz, Alejandro ; Navarro, Jorge M. ; Pizarro, Gemita ; Chaparro, Oscar R. ; Mardones, María Loreto
In Marine Environmental Research January 2026 213
Report
A Phase 1 Study of ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-L1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
Report
Phase IIb Randomised Clinical Trial Repurposing ATRA as a Stromal Targeting Agent in a Novel Drug Combination for Pancreatic Cancer
Kocher HM; BCI-STARPAC2 team; BPTB team; Precision-Panc team; Sasieni P, Corrie P, McNamara MG, Sarker D, Froeling FEM, Christie A, Gillmore R, Khan K, Propper D. Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2. BMC Cancer. 2025 Jan 20;25(1):106. doi: 10.1186/s12885-024-13333-z.
Kocher HM; BCI-STARPAC2 team; BPTB team; Precision-Panc team; Sasieni P, Corrie P, McNamara MG, Sarker D, Froeling FEM, Christie A, Gillmore R, Khan K, Propper D. Study protocol: multi-centre, randomised controlled clinical trial exploring stromal targeting in locally advanced pancreatic cancer; STARPAC2. BMC Cancer. 2025 Jan 20;25(1):106. doi: 10.1186/s12885-024-13333-z.
Report
A Phase Ib Dose De-Escalation Study of All-Trans Retinoic Acid (ATRA ) and Atezolizumab in Patients With Advanced Non-Small Cell Lung Cancer
Academic Journal
Liu J; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Wang L; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Xie M; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Zhao W; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Sun J; Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Jin Y; Department of Basic Medicine, Jilin Medical University, Jilin, People's Republic of China.; Liu M; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Zhao J; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Cheng L; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Wen C; School of clinical medicine, Jilin Medical University, Jilin, People's Republic of China.; Bi X; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.; Huang C; School of Basic Medicine Sciences, Jiangxi Medical College, Nanchang University, Nanchang, People's Republic of China.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 9511366 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-2928 (Electronic) Linking ISSN: 13510002 NLM ISO Abbreviation: Redox Rep Subsets: MEDLINE
Academic Journal
Takase K; Department of Hematology and Clinical Research Institute, NHO Kyushu Medical Center, Fukuoka, Japan.; Kamimura T; Department of Hematology, Harasanshin Hospital, Fukuoka, Japan.; Kuriyama T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.; Tokuyama T; Department of Hematology, Matsuyama Red Cross Hospital, Matsuyama, Japan.; Henzan H; Division of Hematology and Oncology, Department of Medicine, Fukuoka Red Cross Hospital, Fukuoka, Japan.; Kikushige Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.; Choi I; Department of Hematology and Cell Therapy, NHO Kyushu Cancer Center, Fukuoka, Japan.; Imamura Y; Department of Hematology, St. Mary's Hospital, Our Lady of the Snow Social Medical Corporation, Kurume, Japan.; Mori A; Department of Hematology, Aiiku Hospital, Sapporo, Japan.; Ohya S; Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Kurume, Japan.; Kawano N; Department of Internal Medicine, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan.; Yonemoto K; Division of Biostatistics, School of Health Sciences, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan.; Harada M; Karatsu Higashimatsuura Medical Center, Karatsu, Japan.; Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.; Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan.; Department of Hematology, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Academic Journal
Siyu Cheng; Langqun Chen; Jiahui Ying; Ying Wang; Wenjuan Jiang; Qi Zhang; Hong Zhang; Jiahe Wang; Chen Wang; Huimin Wu; Jing Ye; Liang Zhang
Journal of Ginseng Research. 2024-05 48(3):298-309
Academic Journal
Qin, Wangang ; Yu, Youhai ; Ding, Lirong ; Zhou, Hongtian ; Yu, Huiwen ; Lay, Mimi ; Zhuo, Zhanpeng ; Wen, Hao ; Ou, Yangyu ; Huang, Junting ; Jiang, Min ; Yang, Zhanzheng ; Kuang, Suhua ; Long, Fei ; Liang, Zijing ; Liang, Qing
In European Journal of Pharmacology 5 September 2025 1002
Academic Journal
In Marine Environmental Research September 2025 210
Academic Journal
O’Brien, Joseph; Tomlinson, Ben; Patel, Mayher J.; Van Besien, Koen; Brown, Joseph; Lazarus, Hillard; O’Brien, Timothy
Academic Journal
Yang, Huan ; Pu, Yiyao ; Hu, Xueyi ; Zhang, Haili ; Li, Shiyi ; Zhang, Wei ; Chen, Meiwan ; Zhang, Heyang ; Jin, Rongrong ; Nie, Yu
In Journal of Controlled Release 10 August 2025 384
Academic Journal
Medical Oncology. 43(2)
Academic Journal
European Journal of Medical Research. 30(1)
Academic Journal
Kariminejad-Farsangi, Haniyeh; Mirzaee Khalilabadi, Roohollah; Afgar, Ali; Mirzaie, Mahdieh; Mardani Valandani, Hajar
Clinical and Experimental Medicine. 25(1)
Report
A Phase II Study of All-Trans Retinoic Acid (ATRA ) and Cemiplimab in Patients With Advanced Leiomyosarcoma
Report
Venetoclax Plus All-Trans Retinoic Acid and Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia With Hyperleukocytosis: A Prospective Single-Arm Study
Report
A Phase 2 Trial of All-Trans Retinoic Acid (ATRA ) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
검색 결과 제한하기
제한된 항목
[검색어] ATRA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어